Moderna on Thursday submitted a request to the FDA for emergency use authorization for its COVID-19 vaccine in children 6 months to under 6 years of age.
Why it matters: Young children have been largely unprotected throughout the pandemic. The FDA’s approval could ultimately permit them to get a COVID-19 vaccine.
-Efficacy was 43.7% for children ages 6 months to 2 years and 37.5% in children ages 2 to 6, clinical trial data showed.